Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation

Neurology

Volumn 72, Issue 2, 2009, Pages 177-184

  England, J D ^a,r   Gronseth, G S ^b   Franklin, G ^c   Carter, G T ^d   Kinsella, L J ^e   Cohen, J A ^f   Asbury, A K ^g   Szigeti, K ^h   Lupski, J R ^h   Latov, N ⁱ   Lewis, R A ^j   Low, P A ^k   Fisher, M A ^l   Herrmann, D N ^m   Howard, J F ⁿ   Lauria, G ^o   Miller, R G ^p   Polydefkis, M ^q   Sumner, A J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d St John Providence Health System   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k MAYO CLINIC   (United States)

^l LOYOLA UNIVERSITY CHICAGO   (United States)

^m UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o DEPARTMENT OF NEUROSURGERY   (Italy)

^p CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^q DEPARTMENT OF PATHOLOGY   (United States)

^r AMERICAN ACADEMY OF NEUROLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID NEUROPATHY; AUTONOMIC NERVOUS SYSTEM; CELL DENSITY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EMBASE; EVALUATION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL SOCIETY; MEDLINE; MONONEUROPATHY MULTIPLEX; NERVE BIOPSY; NERVE FIBER; PARAMETERS OF MEASUREMENT AND ANALYSIS; POLYNEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENSORY NEUROPATHY; SKIN BIOPSY; VALIDATION PROCESS; VALIDATION THERAPY; VASCULITIS; AUTONOMIC NERVE; AUTONOMIC NEUROPATHY; BIOPSY; ELECTRODIAGNOSIS; INNERVATION; METHODOLOGY; NEUROLOGIC EXAMINATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; SENSORY RECEPTOR; SKIN; STANDARD;

AUTONOMIC NERVOUS SYSTEM DISEASES; AUTONOMIC PATHWAYS; BIOPSY; ELECTRODIAGNOSIS; EVIDENCE-BASED MEDICINE; HUMANS; NEUROLOGIC EXAMINATION; PERIPHERAL NERVES; POLYNEUROPATHIES; SENSORY RECEPTOR CELLS; SKIN;

EID: 60549087147     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000336345.70511.0f     Document Type: Article

References (40)

1. England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207.
2. Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997;62:310-318.
3. England JD, Asbury AK. Peripheral neuropathy. Lancet 2004;363:2151-2161.
4. Low PA, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve 2003;27:646-661.
5. Singer W, Spies JM, McArthur J, et al. Prospective evaluation of somatic and autonomic small fibers in selected neuropathies. Neurology 2004;62:612-618. (Class III)
6. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164-1170. (Class II)
7. Low PA, Denq JC, Opfer-Gehrking TL, Dyck PJ, O'Brien PC, Slezak JM. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve 1997;20:1561-1568. (Class II)
8. Ziegler D, Dannehl K, Muhlen, Spuler M, Gries FA. Presence of cardiovascular autonomic dysfunction assessed by spectral analysis, and standard tests of heart rate variation and blood pressure response at various stages of diabetic neuropathy. Diabet Med 1992;9:806-814.
9. Low PA. Composite Autonomic Scoring Scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752. (Class II)
10. Ebert TJ, Morgan BJ, Barney JA, Denahan T, Smith JJ. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992;263:798-803.
11. Trimarco B, Volpe M, Ricciardelli B, et al. Valsalva maneuver in the assessment of baroreflex responsiveness in borderline hypertensives. Cardiology 1983;70:6-14.
12. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology 2005;65:1533-1537. (Class II)
13. Schrezenmaier C, Singer W, Muenter-Swift N, Sletten D, Tanabe J, Low PA. Adrenergic and vagal baroreflex sensitivity in autonomic failure. Arch Neurol 2007;64:381-386. (Class II)
14. Low PA, Walsh JC, Huang C, McLeod JG. The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study. Brain 1975;98:341-356.
15. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989;64:617-628.
16. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-580.
17. Stewart AG, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 1992;15:661-665. (Class III)
18. Tobin K, Guliani MJ, LaComis D. Comparison of different modalities for detection of small fiber neuropathy. Clin Neurophysiol 1999;110:1909-1912. (Class III)
19. Novak V, Freimer ML, Kissel JT, et al. Autonomic impairment in painful neuropathy. Neurology 2001;56:861-868. (Class III)
20. Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve 1986;9:592-596.
21. Low PA, Opfer-Gehrking TL, Proper CJ, Zimmerman I. The effect of aging on cardiac autonomic and postganglionic sudomotor function. Muscle Nerve 1990;13:152-157.
22. Low PA, Neumann C, Dyck PJ, Fealey RD, Tuck RR. Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc 1983;58:583-592. (Class III)
23. Argov Z, Steiner I, Soffer D. The yield of sural nerve biopsy in the evaluation of peripheral neuropathies. Acta Neurol Scand 1989;79:243-245.
24. Bosboom WMJ, VanderBerg LH, Franssen H, et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 2001; 124:2427-2438.
25. Chia L, Fernandez A, Lacroix C, Adams D, Planté V, Said G. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly: a retrospective review of 100 consecutive patients. Brain 1996;119:1091-1098.
26. Deprez M, Ceuterick-DeGroote C. Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord 2000;10:92-98.
27. Deprez M, Ceuterick-DeGroote C, Schoenen J, Reznik M, Martin JJ. Nerve biopsy: indications and contribution of the diagnosis of peripheral neuropathy. Acta Neurol Belg 2000;100:162-166.
28. Flachenecker P, Janka M, Goldbrunner R, Toyka KV. Clinical outcome of sural nerve biopsy: a retrospective study. J Neurol 1999;246:93-96.
29. Gabriel CM, Howard R, Kinsella N, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442-446.
30. Molenaar DSM, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64:84-89.
31. Rappaport WD, Valente J, Hunter GC, et al. Clinical utilization and complications of sural nerve biopsy. Am J Surg 1993;166:252-256.
32. Said G. Indications and value of nerve biopsy. Muscle Nerve 1999;22:1617-1619.
33. Said G. Value of nerve biopsy. Lancet 2001;357:1220-1221.
34. Said G. Indications and usefulness of nerve biopsy. Arch Neurol 2002;59:1532-1535.
35. Lauria G, Cornblath DR, Johansson O, et al. EFNS Guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005;12:1-12.
36. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998;55: 1513-1520. (Class III)
37. Goranson LG, Mellgren SI, Lindal S, Omdal R. The effect of age and gender on epidermal nerve fiber density. Neurology 2004;62:774-777.
38. Smith AG, Howard JR, Kroll R, et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 2005;228:65-69.
39. Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003;61:631-636. (Class III)
40. Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G, and The North East AIDS Dementia (NEAD) Consortium. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve 2004;29:420-427. (Class III)